ebomi
Colour theme
Sign in
Insider · CIK 0001277631

Baskett Forest

CIK 0001277631 Name as filed on the most recent filing

Filed as Baskett Forest (198)

362 transaction lines · from 198 filings · filed 2005-08-01 to 2026-03-12 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

269 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2018-12-14 P, Open-market purchase Ra Pharmaceuticals, Inc.RARX 9,999,996, acquired Open Form 4 filing 0001209191-18-062803
2018-12-11 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 121,084, acquired Open Form 4 filing 0001209191-18-062249
2018-12-10 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 51,576, acquired Open Form 4 filing 0001209191-18-061835
2018-12-07 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 232,362, acquired Open Form 4 filing 0001209191-18-061835
2018-12-06 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 54,414, acquired Open Form 4 filing 0001209191-18-061835
2018-11-30 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 142,067, acquired Open Form 4 filing 0001209191-18-060416
2018-11-28 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 48,824, acquired Open Form 4 filing 0001209191-18-060416
2018-11-20 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 336,107, acquired Open Form 4 filing 0001209191-18-059738
2018-11-19 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 956,658, acquired Open Form 4 filing 0001209191-18-059346
2018-11-16 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 649,355, acquired Open Form 4 filing 0001209191-18-059346
2018-11-15 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 631,958, acquired Open Form 4 filing 0001209191-18-059346
2018-10-22 P, Open-market purchase PhaseBio Pharmaceuticals IncPHAS 9,000,000, acquired Open Form 4 filing 0001209191-18-056072
2018-09-07 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 2 lines 25,000,500, acquired Open Form 4 filing 0001209191-18-050282
2018-08-21 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 1,499,998, acquired Open Form 4 filing 0001209191-18-047961
2018-07-30 P, Open-market purchase Liquidia Technologies IncLQDA 6,000,005, acquired Open Form 4 filing 0001209191-18-044819
2018-07-19 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 101,165, acquired Open Form 4 filing 0001209191-18-043479
2018-07-18 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 390,580, acquired Open Form 4 filing 0001209191-18-043479
2018-06-28 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 392,692, acquired Open Form 4 filing 0001209191-18-039960
2018-06-27 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 11,384, acquired Open Form 4 filing 0001209191-18-039960
2018-05-30 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 591, acquired Open Form 4 filing 0001209191-18-034186
2018-05-21 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 69,059, acquired Open Form 4 filing 0001209191-18-031983
2018-05-18 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 42,928, acquired Open Form 4 filing 0001209191-18-031983
2018-05-17 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 391,436, acquired Open Form 4 filing 0001209191-18-031983
2018-05-08 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 151,250, acquired Open Form 4 filing 0001209191-18-029295
2018-04-23 P, Open-market purchase Surface Oncology, Inc.SURF 1,999,995, acquired Open Form 4 filing 0001209191-18-025846
2018-04-10 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 499,994, acquired Open Form 4 filing 0001209191-18-024534
2018-04-09 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 78,099, acquired Open Form 4 filing 0001209191-18-024534
2018-04-06 P, Open-market purchase Aveo Pharmaceuticals IncAVEO 1,536,943, acquired Open Form 4 filing 0001209191-18-024534
2018-03-27 P, Open-market purchase Tracon Pharmaceuticals, Inc.TCON 1,911,503, acquired Open Form 4 filing 0001209191-18-021750
2018-03-27 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 11,500,200, acquired Open Form 4 filing 0001209191-18-021939
2018-03-26 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 1,087,553, acquired Open Form 4 filing 0001209191-18-021939
2018-03-23 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 572,358, acquired Open Form 4 filing 0001209191-18-021546
2018-03-22 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 1,655,669, acquired Open Form 4 filing 0001209191-18-021546
2018-03-21 P, Open-market purchase Adaptimmune Therapeutics PLCADAP 189,820, acquired Open Form 4 filing 0001209191-18-021546
2018-03-06 P, Open-market purchase Tesaro, Inc.TSRO 2 lines 944,665, acquired Open Form 4 filing 0001209191-18-017557
2018-03-05 P, Open-market purchase Tesaro, Inc.TSRO 6 lines 3,614,335, acquired Open Form 4 filing 0001209191-18-017557
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 1,428,875, acquired Open Form 4 filing 0001209191-18-017557
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 1,024,114, acquired Open Form 4 filing 0001209191-18-017557
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 357,165, acquired Open Form 4 filing 0001209191-18-017557
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 352,005, acquired Open Form 4 filing 0001209191-18-017557
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 256,043, acquired Open Form 4 filing 0001209191-18-017557
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 231,174, acquired Open Form 4 filing 0001209191-18-017557
2018-03-02 P, Open-market purchase Tesaro, Inc.TSRO 88,015, acquired Open Form 4 filing 0001209191-18-017557

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
Relationships on this page
%, Ten percent owner
Ten percent owner

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 116
  • Open-market sale 153
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. BASKETT FOREST, insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001277631

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.